Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Oct 29, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
DRL filed a 6-K on 10/29/24, standard foreign issuer report.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on October 29, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, Telangana, India, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills.
Why It Matters
This filing indicates ongoing reporting compliance for Dr. Reddy's Laboratories, a significant player in the pharmaceutical industry, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or strategic changes.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001113 (accession_number) — Filing identifier
- October 29, 2024 (date) — Filing date
- Hyderabad, Telangana, India (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Limited to report information.
When was this Form 6-K filed?
The filing was made on October 29, 2024.
Where is Dr. Reddy's Laboratories Limited headquartered?
The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
The filing indicates that the registrant files annual reports under cover of Form 20-F.
What is the SIC code for Dr. Reddy's Laboratories?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-10-29 10:53:26
Filing Documents
- drr0686_6k.htm (6-K) — 13KB
- drr0686_ex99-1.htm (EX-99.1) — 9KB
- drr0686_ex99-1img01.jpg (GRAPHIC) — 3KB
- drr0686_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-001113.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 29, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3